Last €0.92 EUR
Change Today +0.009 / 0.99%
Volume 1.1K
VCC On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 7:53 AM 10/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Vijay B. Samant

Chief Executive Officer, President, Acting Chief Financial Officer and Director, Vical Incorporated
AgeTotal Calculated CompensationThis person is connected to 15 board members in 2 different organizations across 4 different industries.

See Board Relationships
61$1,729,632
As of Fiscal Year 2013

Background*

Mr. Vijay B. Samant has been Chief Executive Officer of Vical Incorporated since 1990 and has been its President since November 2000. Mr. Samant joined Vical Inc. in November 2000 and has been its Acting Chief Financial Officer since April 12, 2013. He has over 23 years of U.S. and International Pharmaceuticals experience in the areas of Sales, Marketing, Operations and Business Development. Previously, Mr. Samant held various positions at Merck & Co., Inc. from 1977 ...

Read Full Background

Corporate Headquarters*

10390 Pacific Center Court
San Diego, California 92121

United States

Phone: 858-646-1100
Fax: 858-646-1150

Board Members Memberships*

2000-Present
Chief Executive Officer, President, Acting Chief Financial Officer and Director
2002-2004
Former Director
2011-2014
Former Director, Member of Compensation Committee and Member of Corporate Governance & Nominating Committee

Education*

MS
Columbia University
MBA
MIT Sloan School of Management
BS
University of Mumbai
BS
University Department of Chemical Technology India

Other Affiliations*

Annual Compensation*

Salary$557,000
Total Annual Compensation$557,000

Stock Options*

Restricted Stock Awards$279,180
All Other Compensation$56,727
Exercisable Options1,460,250
Unexercisable Options848,750
Total Number of Options2,309,000

Total Compensation*

Total Annual Cash Compensation$613,727
Total Short Term Compensation$557,000
Other Long Term Compensation$335,907
Total Calculated Compensation$1,729,632
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VCC:GR €0.92 EUR +0.009

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Douglas J. Swirsky CPA, CFAChief Executive Officer, President, Chief Financial Officer, Principal Accounting Officer, Treasurer, Corporate Secretary and Director
GenVec, Inc.
$316.3K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
$533.3K
Hans Arwidsson Ph.D.Chief Executive Officer and President
Eurocine Vaccines AB
--
William D. Clark Chief Executive Officer, President and Director
Genocea Biosciences, Inc.
$334.3K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VICAL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.